You are here

Home » Content

Türkiye'de bir aile sağlığı merkezinde erişkinlerde metabolik sendrom prevalansı

Prevalence of the metabolic syndrome among adults in a family health center in Turkey

Journal Name:

  • Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2012

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Objective: The purpose of this study was to determine the prevalence of the metabolic syndrome (MetS) in an urban population enrolled at a family health center in the city of Isparta. Material and Method: It was a cross-sectional study. The study population consisted of 8038 individuals aged 20 and over enrolled at Kurtuluş pamily Health Center. The MetS was diagnosed using the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) and the International Diabetes pederation (IDp) criteria. Results: According to ATP III and IDp definitions, the overall prevalence of the MetS was 29.9% and 35.3%, respectively. By both definitions, the prevalence was higher in women than men. por ATP III, it was 32.6% versus 26.7%; while it was 37.9% versus 32.3% for IDp. The prevalence increased significantly by age for both definitions reaching peak levels in the sixth decade. The most common component was low HDL-C (52.1%) for ATP III, however it was abdominal obesity (72.1%) for IDp. Conclusion: There is a high prevalence of MetS in this urban population. Considering our results, it is noteworthy that one third of our population has the risk of developing diabetes and cardiovascular disease. These findings indicate the need for support and promotion of healthy lifestyle behaviors among individuals of our family health center.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Bu çalışmanın amacı İsparta ili kentsel alanında bulunan aile sağlığı merkezimize kayıtlı erişkin bireylerde metabolik sendrom prevalansını belirlemektir. Materyal ve Metod: Araştırma kesitsel tiptedir. Evren, Kurtuluş Aile Sağlığı Merkezi'ne kayıtlı 20 yaş ve üstü 8038 kişidir. Metabolik sendrom (MetS) prevalansı Ulusal Kolesterol Eğitim Programı (NCEP) Erişkin Tedavi Paneli III (ATP III) ve Uluslararası Diyabet pederasyonu (IDp) tanımlamaları kullanılarak belirlenmiştir. Bulgular: ATP III ve IDp tanımlamalarına göre MetS prevalansı sırasıyla % 29.9 ve % 35.3 olarak bulunmuştur. Her iki tanımlamayla da prevalans kadınlarda erkeklere oranla daha yüksektir. ATP III için bu oranlar % 32.6'ya % 26.7 iken, IDp için % 37.9'a % 32.3 düzeylerindedir. Prevalans, her iki tanımlamayla da yaşla birlikte artış göstererek 60-69 yaş grubunda en yüksek düzeye ulaşmıştır. En yüksek oranda saptanan MetS kriteri, ATP III tanımlamasıyla düşük HDL-C (% 52.1) iken IDp tanımlaması ile abdominal obezite (% 72.1) olmuştur. Sonuç: Kentsel alandaki bu toplumda MetS prevalansı yüksek bulunmuştur. Sonuçlarımız değerlendirildiğinde incelenen toplumun yaklaşık üçte biri diyabet ve kardiyovasküler hastalıkların gelişimi açısından risk altındadır. Bu bulgular aile sağlığı merkezimizdeki bireylerde sağlıklı yaşam tarzı davranışlarının teşvik edilmesi ve desteklenmesi ihtiyacını ortaya koymaktadır.
FULL TEXT (PDF): 
PDF icon arastirmax-turkiyede-bir-aile-sagligi-merkezinde-eriskinlerde-metabolik-sendrom-prevalansi.pdf
  • 1
155-160
  • Turkish

REFERENCES

References: 

1. Reaven GM. Banting Lecture 1988: role ofinsulin resistance in human disease. Diabetes 1988; 37: 1595-1607
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2909-2916
3. Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the "metabolic syndrome" and the incidence oftype 2 diabetes. Diabetes 2002; 51: 3120-3127
4. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification ofindividuals at risk oftype 2 diabetes and/or cardiovascular disease? Diabetes Care 2004; 27 (11): 2676-2681
5. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition ofMetabolic Syndrome: Report ofThe National Heart, Lung Blood Institute/American Heart Association Conference on Scientific Issues Relatedto Definition. Circulation2004; 109: 433.438
6. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24 (4): 683-689
7. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications; Part 1: Diagnosis and Classification ofDiabetes Mellitus, Department ofNoncommunicable Disease Surveillance, 1999, Geneva
8. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study ofInsulin Resistance (EGIR). Diab Med 1999; 16 (5): 442-443
9. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment ofHigh Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
10. Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. The Lancet 2005; 366: 1059-1062
11. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin N Am 2004; 33: 351-375
12. Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: a population based study. Am J Epidemiol 1998; 148 (10): 958-966
13. Ford ES. Prevalence ofthe metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005; 28: 2745-9
14. Adams RJ, Appleton S, Wilson DH, Taylor AW, Dal Grande E, Chittleborough C et al. Population comparison oftwo clinical approaches to the metabolic syndrome, Implications ofthe new international diabetes federation consensus definition. Diabetes Care 2005; 28 (11): 2777-2779
15. Can AS, Bersot TP. Analysis of agreement among definitions of metabolic Syndrome in nondiabetic Turkish adults: a methodological study. BMC Public Health2007,7: 353
16. Harzallah F, Alberti H, Ben Khalifa F. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabet Med 2006;23:441-444
17. Boden G, Chen X, DeSantis RA, Kendrick Z. Effects of age and body fat on insulin resistance in healthy men. Diabetes Care 1993; 16: 728-733
18. Kanjilal S, Shanker J, Rao VS, KhadrinarasimhaihN, Mukherjee M, Iyengar SSet al. Prevalence and component analysis ofmetabolic syndrome: An Indian atherosclerosis research study perspective. Vascular Health and Risk Management 2008, 4 (1): 189-197
19. Reddy KS, Prabhakaran D, Chaturvedi V, Jeemon P, Thankappan KR, Ramakrishnan L et al. Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations. Bulletin of the WHO 2006; 84 (6): 461-469
20. Taylor H, Liu J, Wilson G, Golden SH, Crook E, Brunson CD et al. Distinct component profiles and high risk among African Americans with metabolic syndrome: the Jackson Heart Study. Diabetes Care 2008; 31(6): 1248-1253
21. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence ofthe metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 2007; 7: 220
22. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence ofmetabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003; 61: 29-37
23. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults: a population study using modified ATP criteria. Diabetes Res Clin Pract 2003, 60: 199¬204
24. Kozan O, Oguz A, Abaci A, Erol C, Ongen Z, Temizhan A et al. Prevalence ofthe metabolic syndrome among Turkish adults. Eur J Clin Nutr 2007; 61: 548-553
25. Sanisoglu SY, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M. Prevalence ofmetabolic syndrome-related
S.D.Ü. Tıp pak.Derg
. 2012:19(1)/155-160
Özseven,Prevalence of metabolic syndrome
160
disorders in a large adult population in Turkey. BMC Public Health2006; 6: 92
26. Özsahin AK, Gökcel A, Sezgin N, Akbaba M, Güvener N, Özısık I et al. Prevalence ofthe metabolic syndrome in a Turkish adult population. Diabetes Nutr Metab 2004; 17: 230-234
27. Erem C, Hacihasanoglu A, Deger O, Topbas M, Hosver I, Ersöz HO et al. Prevalence ofmetabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study. Endocr 2008; 33: 9-20
28. Khader Y, Bateiha A, El-Khateeb M, Al-Shaikh A, Ajlouni K. High prevalence ofthe metabolic syndrome among Northern Jordanians. J Diabetes Complications 2007;21:214-219
29. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P. Prevalence ofthe metabolic syndrome among Omani adults. Diabetes Care 2003; 26: 1781-1785
30. Yumuk VD, Hatemi H, Tarakci T, Uyar N, Turan N, Bagrıacik N et al. High prevalence of obesity and diabetes mellitus in Konya, a central Anatolian city in Turkey. Diabetes Research and Clinical Practice 2005; 70: 151-158
31. Erem C, Arslan C, Hacihasanoglu A, Deger O, Topbas M, Ukinc K et al. Prevalence ofobesiry and associated risk factors in a Turkish population (Trabzon city, Turkey). Obes Res 2004;12 (7): 1117-1127.

Thank you for copying data from http://www.arastirmax.com